---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042911"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T09:24:30.988666+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CEO Elizabeth Ng takes sabbatical; Director M. Michelle Berrey appointed Interim CEO

## Summary
- Elizabeth Ng notified Board on Oct 23, 2024 of sabbatical for personal reasons.
- Director M. Michelle Berrey appointed Interim CEO, effective immediately.
- Compensation arrangements for Interim CEO not yet determined; will be disclosed later.

## SEC filing metadata
- accession: 0001493152-24-042911
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000149315224042911/0001493152-24-042911-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000149315224042911/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042911
- JSON: https://secwatch.observer/filing/0001493152-24-042911.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042911.txt

## Key facts
- Executive change
  Elizabeth Ng departed as Chief Executive Officer at Ocean Biomedical, Inc..
  - Action: took a sabbatical
  - Role: Chief Executive Officer
  source text: On October 23, 2024, Elizabeth Ng notified the Company’s Board of Directors that she would be taking a sabbatical for personal reasons.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1869974/000149315224042911/0001493152-24-042911-index.htm
- Executive change
  M. Michelle Berrey was appointed as Interim Chief Executive Officer at Ocean Biomedical, Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: Director, M. Michelle Berrey was appointed to act as Interim Chief Executive Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1869974/000149315224042911/0001493152-24-042911-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.